2011/91/EU: Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) Text with EEA relevance
Text
Article-level text, parsed from the formex manifestation.
Article 1
In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratory is authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets: Komipharm International Co. Ltd 1236-6 Jeoungwang-dong 420-450 Siheung-si, Gyeonggi-do South Korea
Article 2
This Decision shall apply from 1 March 2011.
Article 3
This Decision is addressed to the Member States.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions